Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Colorcon
AstraZeneca
Medtronic
Boehringer Ingelheim

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020125

See Plans and Pricing

« Back to Dashboard

NDA 020125 describes ACCURETIC, which is a drug marketed by Pfizer Pharms and is included in one NDA. It is available from two suppliers. Additional details are available on the ACCURETIC profile page.

The generic ingredient in ACCURETIC is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.
Summary for 020125
Tradename:ACCURETIC
Applicant:Pfizer Pharms
Ingredient:hydrochlorothiazide; quinapril hydrochloride
Patents:0
Pharmacology for NDA: 020125
Mechanism of ActionAngiotensin-converting Enzyme Inhibitors
Physiological EffectIncreased Diuresis
Suppliers and Packaging for NDA: 020125
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ACCURETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 020125 NDA Parke-Davis Div of Pfizer Inc 0071-0220 0071-0220-23 90 TABLET, FILM COATED in 1 BOTTLE (0071-0220-23)
ACCURETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 020125 NDA Parke-Davis Div of Pfizer Inc 0071-0222 0071-0222-23 90 TABLET, FILM COATED in 1 BOTTLE (0071-0222-23)
Paragraph IV (Patent) Challenges for 020125
Tradename Dosage Ingredient NDA Submissiondate
ACCURETIC TABLET;ORAL hydrochlorothiazide; quinapril hydrochloride 020125

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG;EQ 10MG BASE
Approval Date:Dec 28, 1999TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength12.5MG;EQ 20MG BASE
Approval Date:Dec 28, 1999TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG;EQ 20MG BASE
Approval Date:Dec 28, 1999TE:ABRLD:Yes

Expired US Patents for NDA 020125

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms ACCURETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 020125-001 Dec 28, 1999   Start Trial   Start Trial
Pfizer Pharms ACCURETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 020125-002 Dec 28, 1999   Start Trial   Start Trial
Pfizer Pharms ACCURETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 020125-003 Dec 28, 1999   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Harvard Business School
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.